Artia Global Partners’s Xenon Pharmaceuticals XENE Stock Holding History

Artia Global Partners’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.78M	Buy	65,000 +25,000	+63%	+$1.15M	0.76%	25
2025 Q4	$1.79M	Hold	40,000	–	–	0.25%	40
2025 Q3	$1.61M	Hold	40,000	–	–	0.25%	37
2025 Q2	$1.25M	Hold	40,000	–	–	0.3%	30
2025 Q1	$1.34M	Hold	40,000	–	–	0.34%	29
2024 Q4	$1.57M	Hold	40,000	–	–	0.56%	28
2024 Q3	$1.57M	Hold	40,000	–	–	0.43%	26
2024 Q2	$1.56M	Hold	40,000	–	–	0.3%	30
2024 Q1	$1.72M	Buy	+40,000	New	+$1.84M	0.35%	31

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artia Global Partners's XENE Position: Q1 2026 in Review

Artia Global Partners increased its Xenon Pharmaceuticals (XENE) stake by 63% in Q1 2026, buying an estimated $1.15M and bringing the position to 65,000 shares worth $3.78M. The position accounts for 0.76% of the portfolio, ranked #25.

Artia Global Partners first reported a position in XENE in Q1 2024 and has held it in 9 quarters since. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.

Artia Global Partners held 65,000 shares of Xenon Pharmaceuticals worth $3.78M as of Q1 2026.
Artia Global Partners bought 25,000 Xenon Pharmaceuticals shares in Q1 2026, an estimated $1.15M.
Xenon Pharmaceuticals made up 0.76% of Artia Global Partners's portfolio in Q1 2026, its #25 holding.
Artia Global Partners first reported a position in Xenon Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.

Based on Artia Global Partners's 13F filing for Q1 2026, filed 15 May 2026.